Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Understanding and improving cellular immunotherapies against cancer: From cell-manufacturing to tumor-immune models
Rachel Ringquist, Delta Ghoshal, Ritika Jain, et al.
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114003-114003
Open Access | Times Cited: 25

Showing 25 citing articles:

Cuproptosis correlates with immunosuppressive tumor microenvironment based on pan-cancer multiomics and single-cell sequencing analysis
Yan Qin, Yanling Liu, Xiaoyun Xiang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 70
Immunotherapy discovery on tumor organoid-on-a-chip platforms that recapitulate the tumor microenvironment
Jie Zhang, Hamed Tavakoli, Lei Ma, et al.
Advanced Drug Delivery Reviews (2022) Vol. 187, pp. 114365-114365
Open Access | Times Cited: 60
Recent Advances of Organ-on-a-Chip in Cancer Modeling Research
Xingxing Liu, Qiuping Su, Xiaoyu Zhang, et al.
Biosensors (2022) Vol. 12, Iss. 11, pp. 1045-1045
Open Access | Times Cited: 41
Insights into the Tumor Microenvironment—Components, Functions and Therapeutics
Kornélia Baghy, Andrea Ladányi, Andrea Reszegi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17536-17536
Open Access | Times Cited: 27
Harnessing 3D in vitro systems to model immune responses to solid tumours: a step towards improving and creating personalized immunotherapies
Zhenzhen Zhou, Yuan Pang, Jingyuan Ji, et al.
Nature reviews. Immunology (2023) Vol. 24, Iss. 1, pp. 18-32
Closed Access | Times Cited: 26
Nanomaterials: small particles show huge possibilities for cancer immunotherapy
Ziyin Chen, Ziqi Yue, Kaiqi Yang, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 35
A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model
Monica Marzagalli, Giorgia Pelizzoni, Arianna Fedi, et al.
Frontiers in Bioengineering and Biotechnology (2022) Vol. 10
Open Access | Times Cited: 32
Microporogen‐Structured Collagen Matrices for Embedded Bioprinting of Tumor Models for Immuno‐Oncology
Daniel S. Reynolds, Irene de Lázaro, Manon L. Blache, et al.
Advanced Materials (2023) Vol. 35, Iss. 33
Closed Access | Times Cited: 17
Adoptive cell therapy for solid tumors beyond CAR-T: Current challenges and emerging therapeutic advances
Tingrui Zhang, Zongguang Tai, Fengze Miao, et al.
Journal of Controlled Release (2024) Vol. 368, pp. 372-396
Closed Access | Times Cited: 7
Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: A potential approach for tumor therapy
Ming Zhang, Tingju Wei, Xiaodan Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
Neoantigen cancer vaccines: a new star on the horizon
Xiaoling Li, Jian You, Liping Hong, et al.
Cancer Biology and Medicine (2023), pp. 1-38
Open Access | Times Cited: 11
Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
Di Chen, Lixia Xu, Mengjuan Xuan, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 9
Open Access | Times Cited: 3
Mesenchymal stem cells-based therapy in liver diseases
Hengtong Han, Weilin Jin, Xun Li
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 15
Engineering Heterogeneous Tumor Models for Biomedical Applications
Zhuhao Wu, Danqing Huang, Jinglin Wang, et al.
Advanced Science (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 7
Organoid co‐culture models of the tumor microenvironment promote precision medicine
Zhaoru Gu, Quanyou Wu, Bingqing Shang, et al.
Cancer Innovation (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 7
Novel Drug Delivery Systems in Colorectal Cancer: Advances and Future Prospects
Raj Kamal, Ankit Awasthi, Priyanka Paul, et al.
Pathology - Research and Practice (2024) Vol. 262, pp. 155546-155546
Closed Access | Times Cited: 2
TRIM72 exerts antitumor effects in breast cancer and modulates lactate production and MCT4 promoter activity by interacting with PPP3CA
Zheng Wang, Haixia Li, Hongxia Wang, et al.
Anti-Cancer Drugs (2022) Vol. 33, Iss. 5, pp. 489-501
Open Access | Times Cited: 10
Translation of cell therapies to treat autoimmune disorders
Jinal M. Mehta, Shivani C. Hiremath, Chishiba Chilimba, et al.
Advanced Drug Delivery Reviews (2023) Vol. 205, pp. 115161-115161
Closed Access | Times Cited: 5
CXC chemokines: Potential biomarker and immunotherapeutic target for uterine corpus endometrial carcinoma
Guang Wang, Juan Fu, Mulin Liu, et al.
PLoS ONE (2024) Vol. 19, Iss. 1, pp. e0277872-e0277872
Open Access | Times Cited: 1
Immune-Cell-Based Therapy for COVID-19: Current Status
Yiyuan Wang, Qinghe Liang, Fengsheng Chen, et al.
Viruses (2023) Vol. 15, Iss. 11, pp. 2148-2148
Open Access | Times Cited: 2
Comprehensive analysis of molecular features, prognostic values, and immune landscape association of m6A-regulated immune-related lncRNAs in smoking-associated lung squamous cell carcinoma
Meng Zhang, Jian Zhang, Yang Liu
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 4
3D Organoid Models in Cancer Immunotherapy: Bioengineering Approach for Personalized Treatment
Syarifah Tiara Noorintan, Chelsie Angelius, Fuad Gandhi Torizal
(2024)
Open Access
Organoid Models in Cancer Immunotherapy: Bioengineering Approach for Personalized Treatment
Syarifah Tiara Noorintan, Chelsie Angelius, Fuad Gandhi Torizal
Immuno (2024) Vol. 4, Iss. 4, pp. 312-324
Open Access
Next generation in vitro tumor models guiding cancer therapy
Eliza Li Shan Fong, N. Gopalakrishna Iyer
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114047-114047
Closed Access | Times Cited: 1
Identification of two immune-related risk score signatures through integrated analysis of multi-omics data in hepatocellular carcinoma
Jie Fu, Zhenyu Cao, Ju Zhang, et al.
Gene (2022) Vol. 829, pp. 146519-146519
Closed Access
Page 1

Scroll to top